p-ANCA as a diagnostic marker in ulcerative colitis

Area of Science:

• Gastroenterology
• Immunology
• Clinical Diagnostics

Background:

• Anti-neutrophil cytoplasmic antibodies (ANCA) are used in diagnosing inflammatory bowel disease (IBD).
• Myeloperoxidase-negative p-ANCA (MPO-negative-p-ANCA) are proposed as a marker for differentiating ulcerative colitis (UC) from Crohn's disease (CD).

Purpose of the Study:

• To determine the frequency of MPO-negative-p-ANCA in patients with IBD.
• To correlate MPO-negative-p-ANCA presence with intestinal and extra-intestinal manifestations in IBD.

Main Methods:

• Sera from IBD patients were tested for MPO-negative-p-ANCA.
• ELISAs were used to assess antibody reactivity against various specificities (Cathepsin G, Lactoferrin, MPO, Elastase, Proteinase 3).
• Clinical data on disease manifestation were collected and correlated with ANCA results.

Main Results:

• MPO-negative-p-ANCA were detected in 68% of UC patients and 21% of CD patients.
• A higher prevalence of MPO-negative-p-ANCA was observed in UC compared to CD.
• Colonic involvement and extraintestinal manifestations showed potential correlation with MPO-negative-p-ANCA.
• No correlation was found with therapy, disease activity, sex, age, extent, or duration of disease.
• No significant reactivity was found against other tested specificities.

Conclusions:

• MPO-negative-p-ANCA may serve as a valuable serological marker for distinguishing UC from CD.
• The presence of MPO-negative-p-ANCA in IBD is associated with specific clinical features, particularly colonic involvement and extraintestinal manifestations.